Post Approval Observational Study to Learn More About How Safe Octocog Alfa is and How Well it Works in Patients With Severe Hemophilia A in India
NCT07446010
·
clinicaltrials.gov ↗
NOT_YET_RECRUITING
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Severe Hemophilia A
Interventions
DRUG:
Octocog alfa
Sponsor
Bayer